ALPS ADVISORS INC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 151 filers reported holding SAGE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$910,418
-55.9%
44,238
+0.7%
0.01%
-55.6%
Q2 2023$2,065,589
+25.1%
43,930
+11.7%
0.02%
+20.0%
Q1 2023$1,650,916
+7.3%
39,345
-2.4%
0.02%
+7.1%
Q4 2022$1,538,186
+21.0%
40,330
+24.3%
0.01%
+16.7%
Q3 2022$1,271,000
+12.3%
32,446
-7.4%
0.01%
+9.1%
Q2 2022$1,132,000
-43.7%
35,038
-42.3%
0.01%
-50.0%
Q1 2022$2,009,000
-30.7%
60,692
-11.0%
0.02%
-33.3%
Q4 2021$2,900,000
-9.2%
68,174
-5.4%
0.03%
+6.5%
Q3 2021$3,194,000
-30.7%
72,078
-11.2%
0.03%
-24.4%
Q2 2021$4,610,000
+1288.6%
81,154
+1729.9%
0.04%
+1266.7%
Q1 2021$332,000
-85.5%
4,435
-88.0%
0.00%
-81.2%
Q3 2017$2,297,000
-14.5%
36,874
+9.4%
0.02%
-15.8%
Q2 2017$2,685,000
+18.2%
33,709
+5.4%
0.02%
+18.8%
Q1 2017$2,272,000
+24.6%
31,975
-10.5%
0.02%
+23.1%
Q4 2016$1,824,000
-3.2%
35,716
-12.7%
0.01%
-13.3%
Q3 2016$1,884,000
+38.8%
40,914
-9.2%
0.02%
+25.0%
Q2 2016$1,357,000
+17.6%
45,044
+25.1%
0.01%0.0%
Q1 2016$1,154,000
-47.9%
36,008
-5.3%
0.01%
-45.5%
Q4 2015$2,217,000
-88.2%
38,021
-14.4%
0.02%
+10.0%
Q3 2015$18,791,000
+814.8%
44,401
+57.8%
0.02%
+11.1%
Q2 2015$2,054,000
+218.0%
28,134
+118.7%
0.02%
+260.0%
Q1 2015$646,00012,8620.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders